Navigation Links
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median follow-up 301 Days) Source: Pluvia Research
Date:4/10/2017

April 10, 2017, a new clinical trial report released today compares the significance of historic results treating Acute Leukemia patients vs clinical trial data reported by Bellicum Pharmaceuticals (NASDAQ: BLCM). The clinical trial review was released by Pluvia Securities Research (PSR).

The report reviews data from 122 malignant and non-malignant patients treated with BPX-501 (Bellicum Pharmaceuticals, clinical trial identifier NCT01865617 & NCT02065869). Leukemia patients treated by Bellicum, (n=35) had an overall survival rate of 94% at 6 months compared to a historical 6 month leukemia survival rate of 78% (source: National Donor Marrow Program)

56 patients with non-malignant blood disorders are also treated in the Bellicum trial. These include patients with Sickle Cell disease, Thalassemia Major and Wiscott-Aldrich. The report issued by PSR compares historical survival of these diseases at 1yr (82-92%) with 100% survival of patients treated by Bellicum BPX-501.

The full PSR Clinical Trial Review of Bellicum BPX-501 is available for free download (here)

For Additional Information Contact:
Steve Pluvia
Pluvia Research
801.824.1549

Read the full story at http://www.prweb.com/releases/2017/04/prweb14229071.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Allegheny Health Network Clinical Trial Examines Regorafenib as Maintenance Therapy for Colon Cancer
2. DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
3. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
4. New DrugDev Educational Webinar Reveals How Biotechs and Smaller Pharmaceutical Companies Gain Site Attention and Engagement by Optimizing Clinical Trial Payments
5. FDAnews Announces — Medical Device Clinical Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance Webinar, April 4, 2017
6. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
7. Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer
8. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
9. Peanut Patch Continues to Show Promise in Extension of Latest Clinical Trial
10. New Clinical Data on Cryoablation For The Treatment Of Early Stage Breast Cancer To Be Presented At Susan G. Komen San Diego
11. ERT Clinical Trial Oversight Selected by Premier Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
Breaking Medicine Technology: